Home
 

Testimonials:


Click Here to Order

Secure Checkout Services
Provided by Createspace.com

 

“NDCR 2009 NEW DRUGS 2002-2008 offers “cruise missile” precision in presenting the most relevant information about new drugs in a format that is easy to read and comprehend. Using the New Drug Comparison Rating (NDCR) system, one can easily determine the relative value of a new drug. The drugs that provide the most significant contribution to managing illness, and offer significant advantages over existing products, are given higher ratings, while those offering little or no gain in managing disease are rated lower. This allows proper selection and use of drug therapy and avoids unnecessary expenditures for certain new drugs that are generally premium priced but offer little, if any, therapeutic gain. The content of NDCR 2009 is current and credible. Any consumer, health professional, insurer/managed care organization or enterprise that objectively evaluates drug therapy could benefit from the content of this book.”


Tim R. Covington, M.S., Pharm.D.
President and CEO
Covington Healthcare Associates, LLC
Birmingham, Alabama




“I think this is an invaluable reference for pharmacists. One of the best aspects of this book is the comparison of the new drug to existing options as this information is oftentimes difficult to find, especially at a quick glance. The ratings guide helps practitioners to identify what role the new drug/product has in therapy.”


Sarah M. Wieczorkiewicz, Pharm.D., BCPS
Clinical Assistant Professor
University of Illinois at Chicago College of Pharmacy




“Authoritative and a “must have” for the healthcare practitioner. When one looks for new drug reviews, one automatically thinks of the contribution of Dan Hussar. His New Drug Comparison Rating scale is invaluable and “cuts to the chase” with the most important information on new drug entities.”


Renee M. Popovich, R.Ph.
Midwestern Regional Medical Center
Zion, Illinois
Nicholas G. Popovich, Ph.D., R.Ph.
Professor and Department Head/Chair
University of Illinois at Chicago College of Pharmacy




“Easy, logical, concise, and helpful reference for making formulary decisions for patients and healthcare committees. The New Drug Comparison Rating system is brilliant and long overdue. I always look forward to your annual updates and insights into the latest new drugs.”


John L. Sykora, Pharmacist/Owner
Abrams & Clark Pharmacy
Long Beach, California